Midodrine, offered by Kureasia Pharma, is a high-quality medication formulated to effectively manage and treat symptomatic orthostatic hypotension (low blood pressure upon standing). This condition often results in dizziness, fainting, or lightheadedness due to a sudden drop in blood pressure when moving to an upright position. Midodrine works as a peripheral alpha-adrenergic agonist, meaning it acts on the blood vessels to cause vasoconstriction (narrowing of blood vessels), which in turn helps to increase blood pressure and improve circulation to vital organs.
Each tablet of Midodrine, available in strengths of 2.5 mg, 5 mg, and 10 mg, is designed for precise dosing flexibility, allowing healthcare professionals to tailor treatment according to individual patient needs. By promoting vascular tone and stabilizing blood pressure, Midodrine enhances patient comfort, mobility, and overall quality of life, especially in individuals suffering from chronic low blood pressure or autonomic dysfunction.
Mechanism of Action:
Midodrine is a prodrug, which means it is converted in the body to its active metabolite, desglymidodrine. This metabolite stimulates alpha-adrenergic receptors in the arterioles and veins, causing the blood vessels to contract. This constriction raises both systolic and diastolic blood pressure without significantly affecting heart rate, making it a valuable therapeutic choice for patients with orthostatic intolerance.
Clinical Uses and Benefits:
Effective in treating orthostatic hypotension caused by autonomic nervous system dysfunction.
Helps prevent dizziness, fatigue, and fainting episodes associated with low blood pressure.
Improves blood flow and oxygen delivery to critical organs.
Useful in certain cases of postural tachycardia syndrome (POTS) and other autonomic disorders.
Provides consistent and predictable results with minimal central nervous system side effects, as it does not cross the blood-brain barrier significantly.
Pharmaceutical Excellence – Kureasia Pharma:
At Kureasia Pharma, every formulation is developed with precision, quality, and patient safety as top priorities. Midodrine tablets are manufactured under strict GMP and WHO-certified facilities, ensuring purity, potency, and efficacy. The tablets feature optimal absorption profiles, offering reliable therapeutic outcomes and patient compliance. Kureasia Pharma’s commitment to innovation and quality ensures that healthcare providers receive trusted medications for the management of cardiovascular and autonomic disorders.
Key Features:
Available in 2.5 mg, 5 mg, and 10 mg strengths.
Provides rapid onset and sustained duration of blood pressure support.
High bioavailability and consistent pharmacokinetic performance.
Well-tolerated with a low incidence of side effects.
Manufactured with advanced pharmaceutical technology for stability and uniformity.
Storage and Handling:
Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.
Disclaimer:
Midodrine should be used only under the supervision of a qualified healthcare professional. Dosage and administration depend on individual patient response and clinical condition.
With Kureasia Pharma’s Midodrine 2.5 mg / 5 mg / 10 mg, patients can experience improved hemodynamic stability, restored confidence in daily activities, and enhanced quality of life through reliable management of orthostatic hypotension